![](https://wp-static.smartkarma.com/../assets/uploaded/2023/07/DailyBriefHealthCareAmerisourceBergenCorpMariMedandmore.png)
In today’s briefing:
- AmerisourceBergen Corporation: Can The OneOncology Investment Become A Game Changer? – Key Drivers
- MariMed, Inc. – MariMed Revolts Against 280E
![](http://www.smartkarma.com/assets/plugins/a3-lazy-load/assets/images/lazy_placeholder.gif)
AmerisourceBergen Corporation: Can The OneOncology Investment Become A Game Changer? – Key Drivers
- AmerisourceBergen managed to exceed analyst expectations in terms of revenue as well as earnings.
- Their successes continue to highlight the worth of their pharmaceutical-centric strategy, which includes critical strategic relationships, specialist leadership, and full global commercialization services.
- OneOncology’s practice management services also complement the company’s existing inventory management, practice analytics, and clinical trial support capabilities.
MariMed, Inc. – MariMed Revolts Against 280E
- On July 12th, MariMed stormed Boston Harbor to protest the unfair tax treatment of US cannabis companies.
- The Boston Tea Party was a protest in 1773 where American colonists dumped British tea into the harbor to protest unfair taxation.
- It fueled the push for independence and played a crucial role in the lead-up to the American Revolution.